JFDA issues clarification on the use of hydroxychloroquine for treating corona patients in Jordan

Jordan

Published: 2020-03-22 13:55

Last Updated: 2020-03-22 14:35


JFDA issues clarification on the use of hydroxychloroquine for treating corona patients in Jordan
JFDA issues clarification on the use of hydroxychloroquine for treating corona patients in Jordan
Roya News Source

The Jordan Food and Drug Administration (JFDA) has confirmed that the use of "hydroxychloroquine" drug for treating COVID-19 patients will be in accordance with the treatment protocol used by the medical team treating corona patients in the Kingdom.

In a statement, the JFDA stressed that it will be identifying which patients would the drug be suitable for, based on their health conditions, confirming that it will be monitoring the side effects of the drug.

"The drug will be used under the supervision of specialized doctors in each of the Ministry of Health, Jordanian Royal Medical Services, King Hussein Hospital, and any hospital that is approved later, the statement indicated.

"There are indications that the drug proved to be effective when given to corona patients," according to the statement.

The JFDA and the national committee for epidemics stress that people shouldn't take the drug as a preventive treatment and that people should follow preventive measures instead, by leaving a social distance.

Read more: Hydroxychloroquine, an old malaria drug, to be used as treatment for coronavirus in Jordan

Latest update: Total number of coronavirus cases reaches 99